log in
Print | Back

Lowenstein Sandler LLP

Andrew P. Erdmann

Andrew P. Erdmann



  • Corporate
  • Corporate Governance & Compliance
  • Capital Markets & Securities
  • Life Sciences

WSG Practice Industries


Lowenstein Sandler LLP
New York, U.S.A.


Andrew advises clients on M&A and private equity transactions, including public company mergers and tender offers, purchases and sales of private businesses, formations and dispositions of joint ventures, and other strategic and financial investments. He also regularly provides general legal counsel to clients with respect to corporate governance, corporate finance, securities, commercial contract and legal compliance matters.

Over the course of his career, Andrew has led and worked on deal teams that have negotiated and closed transactions ranging from several million to several billion dollars in value. Those transactions have involved clients in a wide variety of industries, including software, technology, life sciences, health care, communications, sports, entertainment, asset management, professional services, beverages,  retail, manufacturing, infrastructure, energy (including renewable energy), oil and gas, financial services and real estate.

Clients and colleagues appreciate Andrew’s technical skill, practical approach to solving complex problems, ability to apply his breadth of experience to unique situations, unwavering commitment to serving as a team player, and dedication to realizing client objectives. He regularly acts as a catalyst for completing transactions, while protecting clients’ investments and goals at every turn.

Andrew has worked as a senior attorney in corporate law and business development for Medco Health Solutions, Inc., where he provided legal advice and support in connection with mergers and acquisitions, joint ventures, strategic alliances, and other business development opportunities, with primary responsibility for international initiatives.

Prior to entering the legal profession, Andrew worked for PwC, where he provided clients with tax consulting and compliance services and developed and marketed new tax planning solutions, including a web-based product for delivering tax consulting services.

Bar Admissions

    New York
    New Jersey


Wake Forest University School of Law (J.D. 2005); articles editor, Wake Forest Law Review
James Madison University (B.B.A. 1999)
Areas of Practice

Capital Markets & Securities | Corporate | Corporate Governance & Compliance | Family Office Practice | Life Sciences | Mergers & Acquisitions | Private Equity | Transactions & Advisory Group | Venture Capital & Tech M&A

Professional Career

Significant Accomplishments

Represented PVH Corp., one of the world’s largest apparel companies, in the sale of its Speedo North America business to Pentland Group, the parent company of Speedo International Limited, for $170 million in cash, subject to a working capital adjustment.

Represented NexPhase Capital, LP, an operationally-focused, independent private equity firm, in a strategic partnership with DealerOn Inc., a leading provider of websites, social media marketing, SEO, SEM and internal lead management for car dealerships.

Represented W2O Group, a New Mountain Capital portfolio company and provider of analytics-driven, digital-first marketing services and communications to the healthcare sector, in connection with W2O Group’s acquisition of several businesses, including Arcus Global Media LLC, a medical communications consulting company with expertise in oncology, hematology, transplants and rare diseases and Radius Medical Animation LLC a scientific creative agency that designs interactive and immersive digital media for educational purposes within the healthcare and pharmaceutical industries.

Represented TRANZACT, and its executive management team, a provider of comprehensive, direct-to-consumer sales and marketing solutions for leading insurance carriers in the United States, in its $1.4 billion sale to Willis Towers Watson, a leading global advisory, broking and solutions company.

Represented Aceto Corporation, an international company engaged in the development, marketing, sale and distribution of human health products, pharmaceutical ingredients and performance chemicals, in the $411 million sale of its chemical business assets, plus the payment of cure costs and the assumption of certain liabilities, through a Court-supervised process under Section 363 of the Bankruptcy Code.

WSG's members are independent firms and are not affiliated in the joint practice of professional services. Each member exercises its own individual judgments on all client matters.

HOME | SITE MAP | GLANCE | PRIVACY POLICY | DISCLAIMER |  © World Services Group, 2020